{
  "denotations": [
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 76,
        "end": 87
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 443,
        "end": 454
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "17105675_6",
  "text": "Our results show that genotyping A-241G may help to predict the efficacy of risperidone treatment on the basis that patients with the A allele showed greater improvement than those with the G allele on the overall BPRS ( chi2 = 7.19 , p = 0.007 , p = 0.031 after correction by the program SNPSpD ) , while other polymorphisms , including -141 C Ins/Del , TaqIB , rs1076562 , T939C and TaqIA , did not show any association with the response to risperidone ."
}
